Skip to Content

WPI 2285 (Propafenone Hydrochloride Extended-Release 225 mg)

Pill with imprint WPI 2285 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by Actavis Pharma, Inc..

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2285

Propafenone hydrochloride extended-release 225 mg WPI 2285

Propafenone Hydrochloride Extended-Release

Imprint:
WPI 2285
Strength:
225 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2285

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide